Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Giovanni Caocci, MD, Martino Deidda, Antonio Noto, Christian Cadeddu, Marianna Greco, Maria Pina Simula, Olga Mulas, Daniele Cocco, Claudia Fattuoni, Giuseppe Mercuro, Giorgio La Nasa

Blood (2019) 134 (Supplement_1): 4144.

https://doi.org/10.1182/blood-2019-124323

Published: 2019

Journal Articles

Potential Metabolites with Diagnostic Value in Plasma for Angioimmunoblastic T-Cell Lymphoma By LC-MS Based Untargeted Metabonomics Study

Haiyan Yang, Tao Lei, Cong Li, Haifeng Yu, Zhongjian Chen

Blood (2019) 134 (Supplement_1): 5234.

https://doi.org/10.1182/blood-2019-129897

Published: 2019

Journal Articles

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Clinton Lewis, MD, Haesook T. Kim, PhD, Corey S. Cutler, MD MPH, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Rizwan Romee, MD, Brett Glotzbecker, Prashant Nageshwar, MD, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Paul Richardson, Robert J. Soiffer, MD, Vincent T. Ho, MD

Blood (2018) 132 (Supplement 1): 3376.

https://doi.org/10.1182/blood-2018-99-113130

Published: 2018

Journal Articles

Creatine Kinase Pathway Inhibition Alters GSK3 and WNT Signaling in EVI1-Positive Acute Myeloid Leukemia

Lina Benajiba, Gabriela Alexe, Olivier Hermine, MD PhD, Michael Hemann, Alexandre Puissant, Kimberly Stegmaier, MD

Blood (2017) 130 (Supplement 1): 1191.

https://doi.org/10.1182/blood.V130.Suppl_1.1191.1191

Published: 2017

Journal Articles

Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia

Alexandre Puissant, PhD, Nina Fenouille, PhD, Christopher F. Bassil, BA, Issam Ben-Sahra, PhD, Lina Benajiba, Gabriela Alexe, PhD, Azucena Ramos, Yana Pikman, MD, Michael R. Burgess, MD PhD, Qing Li, MD PhD, Frederic Luciano, PhD, Patrick Auberger, PhD, Ilene Galinsky, MSN, ANPc, Daniel J. DeAngelo, MD PhD, Richard M. Stone, MD, Archibald S. Perkins, MD PhD, Kevin Shannon, MD, Michael T. Hemann, PhD, Kimberly Stegmaier, MD

Blood (2016) 128 (22): 523.

https://doi.org/10.1182/blood.V128.22.523.523

Published: 2016

Journal Articles

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Bingcheng Liu, MD, Ying Wang, MD, Chunlin Zhou, MDPhD, Hui Wei, MDPhD, Dong Lin, MDPhD, Wei Li, MD, Kaiqi Liu, Guangji Zhang, Shuning Wei, Yan Li, MD, Benfa Gong, Yuntao Liu, Yingchang Mi, MD PhD, Jianxiang Wang, MD

Blood (2015) 126 (23): 1301.

https://doi.org/10.1182/blood.V126.23.1301.1301

Published: 2015

Journal Articles

Identification of CKMT1B As a New Target in EVI1-Positive AML

Alexandre Puissant, PhD, Nina Fenouille, PhD, Christopher F. Bassil, BA, Issam Ben-Sahra, PhD, Gabriela Alexe, PhD, Lina Benajiba, Azucena Ramos, Yana Pikman, MD, Michael R. Burgess, MD PhD, Ilene Galinsky, ANP, Daniel J. DeAngelo, MD PhD, Richard M. Stone, MD, Kevin Shannon, MD, Michael T. Hemann, PhD, Kimberly Stegmaier, MD

Blood (2015) 126 (23): 3674.

https://doi.org/10.1182/blood.V126.23.3674.3674

Published: 2015

Journal Articles

Effect of Renal and Hepatic Function on Pomalidomide Dose in Patients with Relapsed/Refractory Multiple Myeloma

Adriana C Rossi, MD, Ekta Aneja, MBBS, Angelique Boyer, David Jayabalan, BSMS, MSc, Tomer M Mark, MD MSc, Roger Pearse, MD PhD, Karen Pekle, NP, Arthur Perry, PA, Morton Coleman, MD, Ruben Niesvizky, MD

Blood (2014) 124 (21): 4754.

https://doi.org/10.1182/blood.V124.21.4754.4754

Published: 2014

Journal Articles

Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression

Blood (2013) 122 (21): 1973.

https://doi.org/10.1182/blood.V122.21.1973.1973

Published: 2013

Journal Articles

Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy

A Kate Sasser, PhD, Tineke Casneuf, PhD, Dhammika Amaratunga, PhD, Volha Tryputsen, PhD, Shaji K Kumar, MD, Vincent Rajkumar, MD, Brett Hall

Blood (2013) 122 (21): 3115.

https://doi.org/10.1182/blood.V122.21.3115.3115

Published: 2013

Journal Articles

Frontline Nilotinib Results In Superior Rates Of Molecular Response Versus Imatinib In Chinese Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): ENESTchina 12-Month Primary Analysis

Xiaojun Huang, Jianxiang Wang, MD, Michele Baccarani, MD, Svetlana Jevtic, Christine-Elke Ortmann, Ye Yuan, Hans D. Menssen, MD, PhD, Giuseppe Saglio, Zhi-Xiang Shen, MD

Blood (2013) 122 (21): 1497.

https://doi.org/10.1182/blood.V122.21.1497.1497

Published: 2013

Journal Articles

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Vinod Bansal, MD, Debra Hoppensteadt, Ph.D., Syed Ahmed, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 4793.

https://doi.org/10.1182/blood.V122.21.4793.4793

Published: 2013

Journal Articles

Rituximab Is an Effective Therapy for Relapsed Thrombotic Thrombocytopenia Purpura

Ahmad Jajeh, MD. MPH

Blood (2012) 120 (21): 5139.

https://doi.org/10.1182/blood.V120.21.5139.5139

Published: 2012

Journal Articles

Efficacy of Administration of Plerixafor (Mozobil®) at 5:00 PM for Stem Cell Mobilization (SCM) in Patients Receiving Autologous Stem Cell Transplant.

Jennifer Tornatta, RN, MSN, ANP-BC, John J. Maciejewski, MD, PhD, Sunita Nathan, MD, Bruce C. McLeod, MD, Darilyn Rhoades, RN, Sridevi Palaparthy, MBA, MS, Henry C. Fung

Blood (2009) 114 (22): 3218.

https://doi.org/10.1182/blood.V114.22.3218.3218

Published: 2009

Journal Articles

Detection of Leukemia in MLL-AF9 Transgenic Mice Using Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy

Deborah DeRyckere, Ph.D., Natalie Serkova, Ph.D., Margaret E. Macy, M.D., Lori A. Gardner, B.A., Paul Jedlicka, M.D., Ph.D., Kendra M. Hasebroock, B.S., Lia Gore, M.D.

Blood (2008) 112 (11): 760.

https://doi.org/10.1182/blood.V112.11.760.760

Published: 2008

Journal Articles

Is Amifostine Effective on the Protection of Mitoxantrone-Induced Acute Cardiotoxicity? A Biochemical and Histopathological Experimental Study.

Gurhan Kadikoylu, MD, Ibrahim Meteoglu, MD, Hulya Aybek, MD, Mete Kalak, MD, Suleyman Demir, MD, Muharrem Balkaya, PhD, Cigdem Yenisey, PhD, Zahit Bolaman, Mutlu Arat, MD

Blood (2006) 108 (11): 4364.

https://doi.org/10.1182/blood.V108.11.4364.4364

Published: 2006

Journal Articles

Long-Term Renal Outcome of Autologous Stem Cell Transplantation in Light Chain Deposition Disease.

Elizabeth C. Lorenz, MD, Morie A. Gertz, MD, Fernando C. Fervenza, MD, Nelson Leung, MD

Blood (2005) 106 (11): 5518.

https://doi.org/10.1182/blood.V106.11.5518.5518

Published: 2005

Journal Articles

Coronary Artery Revascularization Surgery in Hemophiliacs: Patient Experiences That Suggest the Simultaneous Use of Anticoagulant Therapy with Antihemophiliac Factor Replacement in the Perioperative Setting.

John J. McCarthy, Elham Abassi2

Blood (2004) 104 (11): 4074.

https://doi.org/10.1182/blood.V104.11.4074.4074

Published: 2004

Journal Articles

Treatment with an Anti-C3b/iC3b Monoclonal Antibody as an Adjuvant to Rituximab Enhances the Killing of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Cells.

Wu Peng, Xin Zhang, Juan Li, Giorgio Inghirami, Kenichi Takeshita, Andrew Pecora, Steve E. Pincus, Linda L. Nardone, Leslie S. Casey, George L. Spitalny

Blood (2004) 104 (11): 1402.

https://doi.org/10.1182/blood.V104.11.1402.1402

Published: 2004

Journal Articles

Predicitve Value of Pretransplant Testing.

Edward A. Copelan.

Blood (2004) 104 (11): 1144.

https://doi.org/10.1182/blood.V104.11.1144.1144

Published: 2004

NARROW

Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Potential Metabolites with Diagnostic Value in Plasma for Angioimmunoblastic T-Cell Lymphoma By LC-MS Based Untargeted Metabonomics Study

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Creatine Kinase Pathway Inhibition Alters GSK3 and WNT Signaling in EVI1-Positive Acute Myeloid Leukemia

Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Identification of CKMT1B As a New Target in EVI1-Positive AML

Effect of Renal and Hepatic Function on Pomalidomide Dose in Patients with Relapsed/Refractory Multiple Myeloma

Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression

Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy

Frontline Nilotinib Results In Superior Rates Of Molecular Response Versus Imatinib In Chinese Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): ENESTchina 12-Month Primary Analysis

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Rituximab Is an Effective Therapy for Relapsed Thrombotic Thrombocytopenia Purpura

Efficacy of Administration of Plerixafor (Mozobil®) at 5:00 PM for Stem Cell Mobilization (SCM) in Patients Receiving Autologous Stem Cell Transplant.

Detection of Leukemia in MLL-AF9 Transgenic Mice Using Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy

Is Amifostine Effective on the Protection of Mitoxantrone-Induced Acute Cardiotoxicity? A Biochemical and Histopathological Experimental Study.

Long-Term Renal Outcome of Autologous Stem Cell Transplantation in Light Chain Deposition Disease.

Coronary Artery Revascularization Surgery in Hemophiliacs: Patient Experiences That Suggest the Simultaneous Use of Anticoagulant Therapy with Antihemophiliac Factor Replacement in the Perioperative Setting.

Treatment with an Anti-C3b/iC3b Monoclonal Antibody as an Adjuvant to Rituximab Enhances the Killing of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Cells.

Predicitve Value of Pretransplant Testing.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only